Abbott Laboratories (NYSE:ABT) under-valued by 14%
| Website | https://www.abbott.com |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $206,786,297,856 |
| Beta | 0.677005 |
| Average Volume | $5,018,203 |
| Last Dividend | 1.62% |
| Price on Nov 1, 2022 | $99.31 |
| Autochartist™ Valuation | $112.78 |
| Conclusion |
14% under-valued |
| Download Report |
